tirzepatide safety profile Efficacy and of in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Is Tirzepatide Safe? Clinical Evidence

Its also important to note that for patients using Wegovy to reduce heart attack and stroke risk which Australias Therapeutic Goods Administration recently approved it for theres no evidence that cardiovascular benefits will be achieved at lower-than-recommended doses

Before starting Ozempic, healthcare professionals should: Review the patient's most recent diabetic eye screening results Ensure screening is up to date and arrange if overdue Refer patients with sight-threatening or referable retinopathy (e.g., pre-proliferative/proliferative retinopathy or maculopathy) for ophthalmology assessment if not already under specialist care Document baseline HbA1c and discuss realistic expectations for glucose reduction Initiate with caution and coordinate with ophthalmology if retinopathy is present, especially if severe or active For patients without pre-existing retinopathy, participation in the NHS Diabetic Eye Screening Programme at their usual recall interval (annual or every 2 years) typically suffices

Opinions vary greatly regarding the best approach, with the decision often based on local preferences and the availability of specific surgeons

Never inject a solution that looks different from when you first reconstituted it